エーザイの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/02 | 4,170 | 4,280 | 4,160 | 4,271 | +120 | +2.9% | 1,575,000 |
| 2025/05/01 | 4,128 | 4,164 | 4,107 | 4,151 | +33 | +0.8% | 791,200 |
| 2025/04/30 | 4,099 | 4,136 | 4,038 | 4,118 | +42 | +1% | 1,492,500 |
| 2025/04/28 | 4,107 | 4,146 | 4,041 | 4,076 | +3 | +0.1% | 1,238,200 |
| 2025/04/25 | 4,098 | 4,098 | 4,056 | 4,073 | +18 | +0.4% | 822,000 |
| 2025/04/24 | 4,095 | 4,098 | 4,037 | 4,055 | -17 | -0.4% | 817,400 |
| 2025/04/23 | 4,094 | 4,094 | 4,040 | 4,072 | +34 | +0.8% | 1,122,200 |
| 2025/04/22 | 3,986 | 4,038 | 3,966 | 4,038 | +62 | +1.6% | 939,200 |
| 2025/04/21 | 3,990 | 4,015 | 3,968 | 3,976 | -7 | -0.2% | 1,052,000 |
| 2025/04/18 | 3,996 | 3,997 | 3,926 | 3,983 | +95 | +2.4% | 1,334,700 |
| 2025/04/17 | 3,873 | 3,888 | 3,828 | 3,888 | +23 | +0.6% | 1,593,100 |
| 2025/04/16 | 3,745 | 3,910 | 3,734 | 3,865 | +138 | +3.7% | 2,803,000 |
| 2025/04/15 | 3,719 | 3,766 | 3,709 | 3,727 | +31 | +0.8% | 1,003,700 |
| 2025/04/14 | 3,619 | 3,714 | 3,610 | 3,696 | +146 | +4.1% | 1,323,900 |
| 2025/04/11 | 3,514 | 3,570 | 3,468 | 3,550 | -166 | -4.5% | 2,412,400 |
| 2025/04/10 | 3,712 | 3,725 | 3,640 | 3,716 | +214 | +6.1% | 2,745,600 |
| 2025/04/09 | 3,668 | 3,673 | 3,463 | 3,502 | -236 | -6.3% | 2,724,400 |
| 2025/04/08 | 3,744 | 3,781 | 3,710 | 3,738 | +64 | +1.7% | 1,847,200 |
| 2025/04/07 | 3,750 | 3,757 | 3,650 | 3,674 | -268 | -6.8% | 2,671,100 |
| 2025/04/04 | 3,895 | 4,013 | 3,891 | 3,942 | +37 | +0.9% | 2,016,900 |
| 2025/04/03 | 3,800 | 3,941 | 3,792 | 3,905 | -20 | -0.5% | 2,216,900 |
| 2025/04/02 | 4,101 | 4,121 | 3,925 | 3,925 | -180 | -4.4% | 2,969,900 |
| 2025/04/01 | 4,145 | 4,185 | 4,102 | 4,105 | -40 | -1% | 1,454,500 |
| 2025/03/31 | 4,247 | 4,249 | 4,142 | 4,145 | -162 | -3.8% | 2,022,500 |
| 2025/03/28 | 4,300 | 4,316 | 4,260 | 4,307 | -63 | -1.4% | 1,206,900 |
| 2025/03/27 | 4,329 | 4,370 | 4,317 | 4,370 | +49 | +1.1% | 1,396,700 |
| 2025/03/26 | 4,300 | 4,348 | 4,298 | 4,321 | ±0 | ±0% | 1,438,500 |
| 2025/03/25 | 4,311 | 4,335 | 4,293 | 4,321 | +11 | +0.3% | 1,080,100 |
| 2025/03/24 | 4,356 | 4,365 | 4,310 | 4,310 | -22 | -0.5% | 840,700 |
| 2025/03/21 | 4,322 | 4,350 | 4,290 | 4,332 | -15 | -0.3% | 1,697,500 |
| 2025/03/19 | 4,341 | 4,377 | 4,327 | 4,347 | +47 | +1.1% | 788,400 |
| 2025/03/18 | 4,344 | 4,344 | 4,290 | 4,300 | -7 | -0.2% | 1,059,900 |
| 2025/03/17 | 4,274 | 4,320 | 4,268 | 4,307 | +34 | +0.8% | 819,100 |
| 2025/03/14 | 4,226 | 4,279 | 4,220 | 4,273 | +16 | +0.4% | 1,120,400 |
| 2025/03/13 | 4,257 | 4,268 | 4,229 | 4,257 | -11 | -0.3% | 796,800 |
| 2025/03/12 | 4,235 | 4,273 | 4,207 | 4,268 | -2 | ±0% | 1,105,300 |
| 2025/03/11 | 4,259 | 4,299 | 4,245 | 4,270 | -16 | -0.4% | 1,162,900 |
| 2025/03/10 | 4,250 | 4,287 | 4,233 | 4,286 | +55 | +1.3% | 1,118,600 |
| 2025/03/07 | 4,260 | 4,282 | 4,215 | 4,231 | -77 | -1.8% | 1,616,100 |
| 2025/03/06 | 4,268 | 4,308 | 4,245 | 4,308 | +47 | +1.1% | 833,800 |
| 2025/03/05 | 4,270 | 4,287 | 4,224 | 4,261 | +20 | +0.5% | 920,600 |
| 2025/03/04 | 4,245 | 4,303 | 4,225 | 4,241 | -49 | -1.1% | 1,150,100 |
| 2025/03/03 | 4,379 | 4,381 | 4,257 | 4,290 | -19 | -0.4% | 1,274,800 |
| 2025/02/28 | 4,400 | 4,417 | 4,280 | 4,309 | -118 | -2.7% | 2,403,300 |
| 2025/02/27 | 4,432 | 4,450 | 4,398 | 4,427 | -13 | -0.3% | 811,500 |
| 2025/02/26 | 4,400 | 4,440 | 4,370 | 4,440 | +68 | +1.6% | 1,080,200 |
| 2025/02/25 | 4,279 | 4,377 | 4,277 | 4,372 | +93 | +2.2% | 1,217,700 |
| 2025/02/21 | 4,260 | 4,305 | 4,250 | 4,279 | +37 | +0.9% | 831,200 |
| 2025/02/20 | 4,315 | 4,328 | 4,227 | 4,242 | -79 | -1.8% | 1,210,200 |
| 2025/02/19 | 4,364 | 4,380 | 4,315 | 4,321 | -51 | -1.2% | 728,400 |
1～
50
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| エーザイ | 427,100円 | +1.7% | -2.9% | 3.75% | 28.02倍 | 1.47倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| アステラス薬 | 145,800円 | +0.9% | +380.2% | 5.35% | 20.08倍 | 1.72倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 245,700円 | +5.7% | +3.9% | 2.50% | 12.22倍 | 1.62倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| 協和キリン | 219,100円 | -3.5% | -11.3% | 2.74% | 20.12倍 | 1.35倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| 小野薬 | 166,700円 | -3.1% | -63.4% | 4.80% | 15.66倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
